Neutropenia
MONDO:0001475A decrease in the number of neutrophils found in the blood.
Also known as: neutropenia, neutropenic disorder
58 clinical trials for this condition and its sub-types, 34 tagged with Neutropenia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Neutropenia
-
Constitutional neutropenia 2 trials · 28 incl. sub-types
13 sub-types
- Chediak-Higashi syndrome 9 trials
- Severe congenital neutropenia 5 trials · 8 incl. sub-types Sub-types →
- Barth syndrome 5 trials
- WHIM syndrome 1 4 trials
- Glycogen storage disease Ib 3 trials
- Cohen syndrome 1 trial
- Griscelli syndrome type 2 1 trial
- Cyclic hematopoiesis 1 trial
- Hermansky-Pudlak syndrome 2 0 trials
- Lichtenstein syndrome 0 trials
- Neutropenia-monocytopenia-deafness syndrome 0 trials
- Poikiloderma with neutropenia 0 trials
- Primary immunodeficiency syndrome due to p14 deficiency 0 trials
-
ELANE-related neutropenia 0 trials · 1 incl. sub-types
2 sub-types
-
Neonatal alloimmune neutropenia 0 trials
-
Transient neonatal neutropenia 0 trials
Most studied deeper sub-types
-
Could a simple antibiotic keep blood cancer patients out of the hospital?
Disease control Not yet recruitingThis study tests whether taking a daily antibiotic (levofloxacin) can safely reduce infections in people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) who are receiving chemotherapy as outpatients. The trial will randomly assign 75 participants to either lev…
Phase 2 • Sponsor: University of Manitoba • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could early antibiotic stop be safe for kids with cancer?
Disease control Not yet recruitingThis trial looks at whether children with cancer who develop a fever and low white blood cells can safely stop antibiotics earlier than usual. About 136 children will be randomly assigned to either stop antibiotics within 24 hours or continue standard treatment. The goal is to se…
Phase 4 • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug may offer safer CMV prevention for kidney transplant patients
Prevention Not yet recruitingThis study tests if letermovir works as well as valganciclovir in preventing CMV infection in 300 kidney transplant patients who are CMV-positive. Both drugs are given for 90 days after transplant. Researchers will also check if letermovir is easier to tolerate and how long it ta…
Phase 4 • Sponsor: Elisabeth Kincaide • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
New study aims to predict deadly infections in blood cancer patients
Knowledge-focused Not yet recruitingThis study looks at blood cancer patients who carry drug-resistant bacteria in their gut. Researchers want to find out who is most likely to get a serious infection from these bacteria. They will collect rectal swabs and track patients for 90 days to build a prediction tool. The …
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC